RBR-63hzd3
Recruiting
未知
Prospective study of COVID-19 in dialytic patients - VIDA: prospective study of coVId-19 in Dialytic pAtients
Associação Evangélica Beneficente de Minas Gerais0 sitesOctober 6, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Associação Evangélica Beneficente de Minas Gerais
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Dialytic patients from Centros de Nefrologia do Hospital Evangélico de Belo Horizonte; patients with diagnosis of COVID\-19 admited in Hospital Evangélico de Belo Horizonte, older than 18 years old.
Exclusion Criteria
- •Refuse to sign the informed consent form, patients younger than 18 years old and vulnerable populations.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Vaccination Against COVID-19 in Chronic Kidney DiseaseChronic Kidney Disease Stage 5 on DialysisChronic Kidney Disease Stage 5 With TransplantVaccine Response ImpairedNCT04743947Heinrich-Heine University, Duesseldorf400
Completed
Not Applicable
COVI-19 breakthrough infection in hemodialysis patients during an Omicron epidemicJPRN-UMIN000054103Fujita Memorial Hospital207
Completed
Not Applicable
Short Daily Versus Conventional Hemodialysis for COVID-19 PatientsCOVID-19NCT05212675Shahid Beheshti University of Medical Sciences47
Unknown
Not Applicable
COVID-19 Infection in Hemodialysis PatientsCOVID-19 Infection in Hemodialysis PatientsNCT05069532Assiut University100
Recruiting
Not Applicable
Prospective observational study of COVID-19 patients in the TOKUSHUKAI GROUPThe purpose of this study is to collect information of the clinical course of patients with COVID-19 treated at Tokushukai hospitals with and without antiviral drugs and to explore the clinical course in the acute phase, the frequency of severe disease, and frequency of post COVID-19 condition by the treatment, after adjusting by patient background including risk factor(s) and symptoms at the time of registration.JPRN-UMIN000053506Shionogi & Co., Ltd.30,000